InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Biobillionair post# 175777

Tuesday, 02/12/2019 9:10:46 AM

Tuesday, February 12, 2019 9:10:46 AM

Post# of 424152
I'm guessing the following is going to be negotiated within Amarin's First Amendment rights regarding Vascepa promotion:

Anti-inflammatory effects in diseases such as: cancer, asthma, rheumatoid arthritis, osteoporosis, dry eye disease, and age-related macular degeneration

anti-inflammatory effects in diseases such as cancer, asthma, rheumatoid arthritis, osteoporosis, dry eye disease, age-related macular degeneration, coronary heart disease and sepsis.



Likely the reason why the FDA cherry picked out the above quotes....

Again link to letter:https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm630564.htm

Thanks to Baa and ST

BB

I do not pump Amarin stock. I am not an Amarin cheerleader. If I see something I don't like I make it known. Patients come first, always!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News